Navigation Links
AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media

LOUISVILLE, Ky., Sept. 14 /PRNewswire/ -- AAF(R) International, manufacturer of American Air Filter and AAF products, is proud to announce the MEGAcel(TM) I filter with Helior(TM) media.

Helior media used in the MEGAcel I filter is a proprietary, high-efficiency ePTFE media offering a lower initial pressure drop than conventional micro-fiberglass media. With a significantly lower operating resistance, energy consumption is less as a result of the decrease in required fan motor horsepower. This substantial energy reduction creates subsequent cost savings for the customer.

The MEGAcel I filter is engineered for energy-efficient operation in a variety of applications, including healthcare, pharmaceutical, electronic, food processing and laboratory environments. MEGAcel I filters are constructed using tapered aluminum separators to optimize pleat pack resistance. MEGAcel I filter with Helior media is highly resistant to corrosive environments, therefore reducing the risk of change-outs due to filter media degradation. Helior media is extremely durable with a tensile strength 8 times that of standard micro-fiberglass media. This provides a lower susceptibility to damage thereby reducing repairs in production and installation - resulting in higher yields. Helior HEPA/ULPA media was developed by AAF and is manufactured and tested in an ISO Class 7 environment, eliminating any potential for contamination.

AAF International, which is based in Louisville, Kentucky, has more than 2,600 employees, 25 manufacturing facilities and 5 R&D centers worldwide supporting sales offices in 69 countries. AAF designs, develops, and manufactures air filtration solutions for commercial, residential, industrial, clean room, transportation, fossil fuel plants and nuclear power applications. It also provides inlet air cooling and sound attenuation solutions for high-speed rotating machinery.

SOURCE AAF International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test
2. Neogen Corporation Announces 1st Quarter Results Conference Call
3. MDS Announces CEO Transition Plan
4. Sunlight Saunas Celebrates 10 Years of Industry Firsts, and Announces 10th Anniversary Sweepstakes Winner
5. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
6. HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call
7. Nielsen Announces First-Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC
8. Forman Perry Watkins Krutz & Tardy Announces Take-Nothing Verdict in Mississippi Asbestos Exposure Trial
9. Abbott Announces TCT 2009 Activities
10. MHA Announces Release of RxPertise(TM) 8.0
11. CSL Biotherapies Announces FDA Marketing Approval of its Monovalent Pandemic (H1N1) 2009 Influenza A Vaccine
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: